Literature DB >> 18940308

Civilian and military genetics: nondiscrimination policy in a post-GINA world.

Susannah Baruch1, Kathy Hudson.   

Abstract

Evidence is emerging of a growing societal consensus about appropriate and inappropriate uses of genetic information. The Genetic Information Nondiscrimination Act of 2008 provides new legal protections to Americans by prohibiting the discriminatory use of genetic information by health insurers and employers. Additionally, the United States military recently created new policies for fair use of genetic information in the determination of benefits for servicemen and servicewomen leaving military service. Although critical issues remain, such as the potential for genetic information to be used to deny people other forms of insurance, and how the military will use genetic medicine overall, significant progress has been made.

Entities:  

Mesh:

Year:  2008        PMID: 18940308      PMCID: PMC2561935          DOI: 10.1016/j.ajhg.2008.09.003

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  47 in total

1.  Genetic testing and discrimination: how private is your information?

Authors:  Louise McIntosh Slaughter
Journal:  Stanford Law Pol Rev       Date:  2006

2.  Genetic exceptionalism and legislative pragmatism.

Authors:  Mark A Rothstein
Journal:  J Law Med Ethics       Date:  2007       Impact factor: 1.718

3.  Prohibiting genetic discrimination.

Authors:  Kathy L Hudson
Journal:  N Engl J Med       Date:  2007-05-17       Impact factor: 91.245

4.  Keeping your genes private.

Authors:  Mark A Rothstein
Journal:  Sci Am       Date:  2008-09       Impact factor: 2.142

5.  Perceptions of genetic testing for cancer predisposition among Ashkenazi Jewish women.

Authors:  M Jane Lewis; Susan K Peterson
Journal:  Community Genet       Date:  2007

6.  Patients' and physicians' perspectives on pharmacogenetic testing.

Authors:  Anja Rogausch; Daniela Prause; Anne Schallenberg; Jürgen Brockmöller; Wolfgang Himmel
Journal:  Pharmacogenomics       Date:  2006-01       Impact factor: 2.533

7.  Managing genetic discrimination: strategies used by individuals found to have the Huntington disease mutation.

Authors:  Y Bombard; E Penziner; J Decolongon; M L N Klimek; S Creighton; O Suchowersky; M Guttman; J S Paulsen; J L Bottorff; M R Hayden
Journal:  Clin Genet       Date:  2007-03       Impact factor: 4.438

8.  Access to health insurance: experiences and attitudes of those with genetic versus non-genetic medical conditions.

Authors:  Nancy E Kass; Amy M Medley; Marvin R Natowicz; Sara Chandros Hull; Ruth R Faden; Laura Plantinga; Lawrence O Gostin
Journal:  Am J Med Genet A       Date:  2007-04-01       Impact factor: 2.802

9.  Genetic discrimination in health insurance: current legal protections and industry practices.

Authors:  Karen Pollitz; Beth N Peshkin; Eliza Bangit; Kevin Lucia
Journal:  Inquiry       Date:  2007       Impact factor: 1.730

10.  Genetic screening for iron overload: No evidence of discrimination at 1 year.

Authors:  Mark A Hall; James C Barton; Paul C Adams; Christine E McLaren; Jacob A Reiss; Oswaldo Castro; Andrea Ruggiero; Ronald T Acton; Tara E Power; Thomas C Bent
Journal:  J Fam Pract       Date:  2007-10       Impact factor: 0.493

View more
  24 in total

Review 1.  Genetic testing in psychiatry: a review of attitudes and beliefs.

Authors:  Ryan E Lawrence; Paul S Appelbaum
Journal:  Psychiatry       Date:  2011       Impact factor: 2.458

Review 2.  Genetics for the general internist.

Authors:  Christina M Laukaitis
Journal:  Am J Med       Date:  2011-11-11       Impact factor: 4.965

3.  Factors associated with experiences of genetic discrimination among individuals at risk for Huntington disease.

Authors:  Yvonne Bombard; JoAnne Palin; Jan M Friedman; Gerry Veenstra; Susan Creighton; Jane S Paulsen; Joan L Bottorff; Michael R Hayden
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2010-11-10       Impact factor: 3.568

Review 4.  Autosomal dominant polycystic kidney disease: the last 3 years.

Authors:  Vicente E Torres; Peter C Harris
Journal:  Kidney Int       Date:  2009-05-20       Impact factor: 10.612

5.  Factors which impact the delivery of genetic risk assessment services focused on inherited cancer genomics: expanding the role and reach of certified genetics professionals.

Authors:  Cristi Radford; Anya Prince; Karen Lewis; Tuya Pal
Journal:  J Genet Couns       Date:  2013-12-04       Impact factor: 2.537

Review 6.  Ethical issues of predictive genetic testing for diabetes.

Authors:  Susanne B Haga
Journal:  J Diabetes Sci Technol       Date:  2009-07-01

7.  Ethics watch: the G.I. genome: ethical implications of genome sequencing in the military.

Authors:  Megan Allyse; Lauren C Milner; Mildred K Cho
Journal:  Nat Rev Genet       Date:  2011-08-02       Impact factor: 53.242

8.  Family physicians' awareness and knowledge of the Genetic Information Non-Discrimination Act (GINA).

Authors:  Amanda L Laedtke; Suzanne M O'Neill; Wendy S Rubinstein; Kristen J Vogel
Journal:  J Genet Couns       Date:  2011-09-07       Impact factor: 2.537

Review 9.  Genetic testing for kidney disease of unknown etiology.

Authors:  Thomas Hays; Emily E Groopman; Ali G Gharavi
Journal:  Kidney Int       Date:  2020-04-24       Impact factor: 10.612

Review 10.  Genetic risk assessments in individuals at high risk for inherited breast cancer in the breast oncology care setting.

Authors:  Tuya Pal; Susan T Vadaparampil
Journal:  Cancer Control       Date:  2012-10       Impact factor: 3.302

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.